It is essential that SMEs consider protecting their creations through intellectual property and efficiently manage these assets to reap the most from their investment in Europe.
Rapid digital transformation, as well as forthcoming innovation of the digital economy, has brought new challenges and opportunities for businesses, legislators, and consumers in the Intellectual Property (IP) sector.
The SEA pharmaceutical market presents both opportunities and challenges that require SMEs to have a solid IP strategy to ensure their business’ upswing.